GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Evelo Biosciences EVLO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Evelo Biosciences — daily EVLO Delayed
Market value
$1,893
Last close × shares
Volume
133
Shares, 30 Oct 2026

About Evelo Biosciences

Its shares trade under the ticker EVLO. It has been listed since 9 May 2018.

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The company is headquartered in Cambridge, Massachusetts. The company went IPO on 2018-05-09. The firm develops monoclonal microbes that are orally-delivered compositions of specific strains of naturally occurring microbes derived from a single clone. Its principal product candidates include EDP1066, EDP1815, and EDP1503 that are in the pre-clinical development stage. EDP1066 and EDP1815 are monoclonal microbial product candidates that are developed to treat inflammatory diseases that include psoriasis, atopic dermatitis, rheumatoid arthritis, and ulcerative colitis. EDP1503 is the Company's product candidate developed under oncology portfolio to treat diseases, such as colorectal cancer, renal cell carcinoma, and melanoma among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Evelo Biosciences →

Latest on Evelo Biosciences

Our reporting

We have not reported on Evelo Biosciences yet.

Next results

17 Nov 2026

Due on 17 Nov 2026. Analysts expect earnings of -10.13 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Evelo Biosciences's ticker?

Evelo Biosciences trades as EVLO on its US listing, under ISIN US2997342025.

What was Evelo Biosciences's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

When does Evelo Biosciences next report results?

Results are expected on 17 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.